Small Molecules that Delay s Phase Suppress a Zebrafish Bmyh Mutant

Nature Chemical Biology

Volumn 1, Issue 7, 2005, Pages 366-370

  Stern, Howard M ^a,b   Murphey, Ryan D ^b   Shepard, Jennifer L ^b   Amatruda, James F ^b   Straub, Christian T ^b   Pfaff, Kathleen L ^b   Gerhard, Weber ^b   Tallarico, John A ^b   King, Randall W ^b   Zon, Leonard I ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTANE; CYCLIN B; CYCLIN B1; DRUG DERIVATIVE; MESSENGER RNA; PERSYNTHAMIDE; PROTEIN C MYB; PYRIDINE DERIVATIVE;

ANIMAL; ARTICLE; CELL CYCLE; CELL CYCLE S PHASE; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MITOSIS; MUTATION; PHENOTYPE; PHYSIOLOGY; PRENATAL DEVELOPMENT; ZEBRA FISH;

ADAMANTANE; ANIMALS; CELL CYCLE; CYCLIN B; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MITOSIS; MUTATION; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-MYB; PYRIDINES; RNA, MESSENGER; S PHASE; ZEBRAFISH;

EID: 33644788489     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio749     Document Type: Article

References (28)

1. Sala, A. & Watson, R. B-Myb protein in cellular proliferation, transcription control, and cancer: latest developments. J. Cell. Physiol. 179, 245–250 (1999).
2. Oh, I.H. & Reddy, E.P. The myb gene family in cell growth, differentiation and apoptosis. Oncogene 18, 3017–3033 (1999).
3. Joaquin, M. & Watson, R. J. Cell cycleregulation by the B-Mybtranscription factor. Cell. Mol. Life Sci. 60, 2389–2401 (2003).
4. Bessa, M., Joaquin, M., Tavner, F., Saville, M.K. & Watson, R.J. Regulation of the cell cycle by B-Myb. Blood Cells Mol. Dis. 27, 416-421 (2001).
5. Shepard, J.L. et al. A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility. Proc. Natl. Acad. Sci. USA 102, 13194-13199 (2005).
6. Peterson, R.T., Link, B.A., Dowling, J.E. & Schreiber, S.L. Small molecule developmental screensreveal thelogicandtimingofvertebratedevelopment. Proc. Natl. Acad. Sci. USA 97, 12965-12969 (2000).
7. Khersonsky, S.M. et al. Facilitated forward chemical genetics using a tagged triazine library and zebrafish embryo screening. J. Am. Chem. Soc. 125, 11804-11805 (2003).
8. Hendzel, M.J. et al. Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106, 348-360 (1997).
9. Nasevicius, A. & Ekker, S.C. Effective targeted gene ‘knockdown’ in zebrafish. Nat. Genet. 26, 216-220 (2000).
10. Feijoo, C. et al. Activation of mammalian Chk1 during DNA replication arrest: a role for Chk1 in the intra-S phase checkpoint monitoring replication origin firing. J. Cell Biol. 154, 913-923 (2001).
11. Sorensen, C.S. et al. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell 3, 247-258 (2003).
12. Zou, L. & Elledge, S.J. Sensing DNA damage through ATRIP recognition of RPA-ss DNA complexes. Science 300, 1542-1548 (2003).
13. Donaldson, A.D. & Blow, J.J. DNA replication: stable driving prevents fatal smashes. Curr. Biol. 11, R979-R982 (2001).
14. Tercero, J.A., Longhese, M.P. & Diffley, J.F. A central role for DNA replication forks in checkpoint activation and response. Mol. Cell 11, 1323-1336 (2003).
15. Shiloh, Y. ATM and ATR: networking cellular responses to DNA damage. Curr. Opin. Genet. Dev. 11, 71-77 (2001).
16. Costanzo, V. et al. An ATR- and Cdc7-dependent DNA damage checkpoint that inhibits initiation of DNA replication. Mol. Cell 11, 203-213 (2003).
17. Cortez, D. Caffeine inhibits checkpoint responses without inhibiting the ataxia-telangiectasia-mutated (ATM) and ATM- and Rad3-related (ATR) protein kinases. J. Biol. Chem. 278, 37139-37145 (2003).
18. Okada, M., Akimaru, H., Hou, D.X., Takahashi, T. & Ishii, S. Myb controls G(2)/M progression by inducing cyclin B expression in the Drosophila eye imaginal disc. EMBO J. 21, 675-684 (2002).
19. Zhu, W., Giangrande, P.H. & Nevins, J.R. E2Fs link the control of G1/S and G2/M transcription. EMBO J. 23, 4615-4626 (2004).
20. Stern, H.M. & Zon, L.I. Cancer genetics and drug discovery in the zebrafish. Nat. Rev. Cancer 3, 533-539 (2003).
21. MacRae, C.A. & Peterson, R.T. Zebrafish-based small molecule discovery. Chem. Biol. 10, 901-908 (2003).
22. Pichler, F.B. et al. Chemical discovery and global gene expression analysis in zebrafish. Nat. Biotechnol. 21, 879-883 (2003).
23. Peterson, R.T., Mably, J.D., Chen, J.N. & Fishman, M.C. Convergence of distinct pathways to heart patterning revealed by the small molecule concentramide and the mutation heart-and-soul. Curr. Biol. 11, 1481-1491 (2001).
24. Peterson, R.T. et al. Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat. Biotechnol. 22, 595-599 (2004).
25. Berghmans, S. et al. tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc. Natl. Acad. Sci. USA 102, 407-412 (2005).
26. Amsterdam, A. et al. Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol. 2, E139 (2004).
27. Langenau, D.M. et al. Myc-induced Tcell leukemia in transgenic zebrafish. Science 299, 887-890 (2003).
28. Patton, E.E. et al. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr. Biol. 15, 249-254 (2005).